1. Home
  2. Stock quotes
  3. Y-mAbs Therapeutics
  4. Financial Statements
  5. Income Statement
  6. Cost of Revenue
Y-mAbs Therapeutics logo
Y-mAbs Therapeutics YMAB
$ 8.27 -3.56%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Y-mAbs Therapeutics Cost of Revenue 2011-2024 | YMAB

Annual Cost of Revenue Y-mAbs Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
11.4 M 7.47 M 2.3 M - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
11.4 M 2.3 M 7.05 M

Quarterly Cost of Revenue Y-mAbs Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
2.25 M 3.01 M 2.1 M - 2.6 M 4.65 M 2.08 M - 2.48 M 1.14 M 1.83 M - 550 K 200 K 93 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
4.65 M 93 K 1.91 M